TFCP2 and chronic obstructive pulmonary disease: PBMCs with downregulated TFCP2 of patients with COPD might have less capacity of the transcriptional switch of globin gene promoters, many other cellular and viral gene promoters, or interaction with certain inflammatory response factors, although the exact mechanism and pathological role remain unclear.